|
|
|
Volumn , Issue 113, 2008, Pages 1-6
|
|
Continuous erythropoietin receptor activator (Mircera) for renal anemia.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ERYTHROPOIETIN;
ERYTHROPOIETIN RECEPTOR;
MACROGOL DERIVATIVE;
ANEMIA;
ARTICLE;
CANADA;
DRUG APPROVAL;
ECONOMICS;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
KIDNEY DISEASE;
METABOLISM;
PHASE 3 CLINICAL TRIAL;
RENAL REPLACEMENT THERAPY;
TIME;
TREATMENT OUTCOME;
UNITED STATES;
ANEMIA;
CANADA;
CLINICAL TRIALS, PHASE III AS TOPIC;
DRUG APPROVAL;
ERYTHROPOIETIN;
HUMANS;
KIDNEY DISEASES;
POLYETHYLENE GLYCOLS;
RECEPTORS, ERYTHROPOIETIN;
RENAL DIALYSIS;
TIME FACTORS;
TREATMENT OUTCOME;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 41949135761
PISSN: 14886324
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
